KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Other financing activities (2016 - 2025)

Historic Other financing activities for Labcorp Holdings (LH) over the last 14 years, with Q3 2025 value amounting to -$1.6 million.

  • Labcorp Holdings' Other financing activities rose 9266.06% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.9 million, marking a year-over-year increase of 9897.35%. This contributed to the annual value of -$36.7 million for FY2024, which is 8724.49% down from last year.
  • As of Q3 2025, Labcorp Holdings' Other financing activities stood at -$1.6 million, which was up 9266.06% from -$4.0 million recorded in Q2 2025.
  • Labcorp Holdings' Other financing activities' 5-year high stood at $1.6 billion during Q2 2023, with a 5-year trough of -$1.5 billion in Q4 2023.
  • Its 4-year average for Other financing activities is -$8.4 million, with a median of -$4.0 million in 2024.
  • As far as peak fluctuations go, Labcorp Holdings' Other financing activities crashed by 552703.7% in 2023, and later soared by 9953.93% in 2024.
  • Over the past 4 years, Labcorp Holdings' Other financing activities (Quarter) stood at -$27.0 million in 2022, then plummeted by 5527.04% to -$1.5 billion in 2023, then surged by 99.54% to -$7.0 million in 2024, then soared by 77.14% to -$1.6 million in 2025.
  • Its last three reported values are -$1.6 million in Q3 2025, -$4.0 million for Q2 2025, and -$3.3 million during Q1 2025.